Colombia Pharma and Healthcare Sector Report 2025-2026

Colombia was the fourth largest pharmaceutical market in Latin America in 2024 in terms of sales value, with a 7.6% share of the Latin American market. The country has a large and growing population and a near-universal social security health insurance system, which suffers from chronic underfunding. After multiple failed attempts to reform the system through Congress, the Colombian government adopted a partial reform by decree in July 2025, with the main provision being a dilution of the role of EPS companies, particularly in decision-making when assigning patients to health centres.

This report provides a complete and detailed analysis of the "Healthcare and pharma" sector for Colombia. EMIS Insights presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:

• Understand the key elements at play in the "Healthcare and pharma" sector in Colombia
• Crystallise the forces both driving and restraining this sector in Colombia
• Ascertain Colombia’s position in the global sector
• Build a complete perspective on sector trade, investment and employment
• Understand the competitive landscape and who the major players are
• View M&A activity and major deals
• Gain an understanding of the regulatory environment for the sector in Colombia.
• Build a clear picture of trends, output and consumption for specific sub-sectors